Original articles \ Review Articles
Coronary physiology at the cath lab
a Unidad de Hemodinámica, Servicio de Cardiología, Hospital Universitari i Politecnic La Fe, Valencia, Spain
b Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
c Departamento de Cardiología Intervencionista, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Departamento de Cardiología Intervencionista, Hospital General ISSSTE Querétaro, Universidad Autónoma de Querétaro, Santiago de Querétaro, Querétaro, Mexico
e Interventional Cardiology, MedStar Washington Hospital Center, Washington DC, United States
REC Interv Cardiol. 2022;4:319-328
Calcified coronary artery disease: pathophysiology, intracoronary imaging assessment, and plaque modification techniques
Instituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain
REC Interv Cardiol. 2022;4:216-227
Intracoronary imaging: review and clinical use
aUnidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital del Mar, Barcelona, Spain
bInstituto Hospital del Mar de Investigaciones Médicas-IMIM, Barcelona, Spain
cCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
REC Interv Cardiol. 2022;4:228-237
Interventional heart failure therapies: an emerging field in interventional cardiology
aDepartamento de Cardiología, Germans Trias i Pujol University Hospital, Badalona, Barcelona, Spain
bDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, United States
REC Interv Cardiol. 2022;4:132-136
Intraoperative echocardiographic assessment of mitral regurgitation after mitral clip implantation: literature review
aServicio de Cardiología, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain
bInstituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain
REC Interv Cardiol. 2022;4:47-56
Ongoing large randomized clinical trials on complex percutaneous coronary interventions: intravascular imaging-guided trials
aInterventional Cardiology, MedStar Washington Hospital Center, Washington DC, United States
bThoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
REC Interv Cardiol. 2021;3:297-303
State-of-the-art and future perspective of percutaneous interventions for the management of STEMI
Servicio de Cardiología, Hospital Clínic, Institut Clínic Cardiovascular, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
REC Interv Cardiol. 2021;3:204-212
Percutaneous treatment of pulmonary valve and arteries for the management of congenital heart disease
Servicio de Cardiología Infantil, Hospital Universitario La Paz, Madrid, Spain
REC Interv Cardiol. 2021;3:119-128
Left main coronary artery percutaneous revascularization: alea jacta est
Sección de Hemodinámica, Servicio de Cardiología, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain
REC Interv Cardiol. 2021;3:45-54
Left ventricular assist devices in acute cardiovascular care patients and high-risk percutaneous coronary interventions
aServicio de Cardiología, Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, Spain
bInterventional Cardiology, The Center for Structural Heart Disease, Interventional Cardiology, Henry Ford Hospital, Detroit, Michigan, United States
cDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States
REC Interv Cardiol. 2020;2:280-287
Page 2 of 3